Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CNSY — Cerenome, Inc.

CIK 1214717 BOSTON, MA
Back to CNSY Full portfolio

Position in CNSY

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$332,797
+$332,797 QoQ
Shares Held
76,155
-96.2% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 22 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNSY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. CNSY ranks #377 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CNSY

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $332,797 76,155
2026-03-31 — 2,016,314
2025-12-31 — 1,402,794
2025-09-30 — 813,250
2025-06-30 — 51,176
2025-03-31 — 57,053
2024-12-31 — 58,150
2024-09-30 — 54,274
2024-06-30 — 46,648
2024-03-31 — 29,263
2023-12-31 — 26,543
2023-09-30 — 26,543
2023-06-30 — 17,007
2023-03-31 — 255,148
2022-12-31 — 258,052
2022-09-30 — 258,437
2022-06-30 — 258,437
2022-03-31 — 258,437
2021-12-31 — 258,437
2021-09-30 — 258,437
2021-06-30 — 130,793